Given that NLRP3 inflammasome activation is correlated with the pathogenesis of various diseases, including neurological disorders,[46, 47, 48] autoimmune diseases,[49, 50] and metabolic diseases,[51, 52] blocking the NLRP3 inflammasome activation pathway is widely considered an effective treatment for inflammatory diseases. The gene discussed is NLRP3; the disease is metabolic disease.